Literature DB >> 3485678

Interleukin 1: a common endogenous mediator of inflammation and the local Shwartzman reaction.

G Beck, G S Habicht, J L Benach, F Miller.   

Abstract

In this study we investigated the role of interleukin 1 (IL 1) in the induction of inflammatory lesions and in the preparation and provocation of the local Shwartzman reaction. Both of these phenomena can be induced with a variety of agents. This suggested to us that a common endogenous mediator may be crucial to the development of these two lesions. When IL 1 was injected intradermally into shaved rabbit backs, 51Cr-labeled neutrophils accumulated at the injection site. Neutrophils began to accumulate less than 1 hr after injection, and the maximum rate of accumulation was observed by 4 hr. This activity was dose dependent. It was calculated that in all animals, 10(-14) mol of IL 1 induced significant neutrophil accumulation, whereas in many animals, as little as 10(-15) mol of IL 1 sufficed. When 4.2 X 10(-9) mol of E. coli 0111:B4 lipopolysaccharide W was injected i.v. 24 hr after an intradermal injection of IL 1 (2.9 X 10(-13) mol), a local Shwartzman reaction was seen 4 hr later at the intradermal injection site. IL 1 injected i.v. 24 hr after an intradermal injection of either IL 1 or lipopolysaccharide also produced a local Shwartzman reaction. These data indicate that IL 1 may be the common endogenous mediator of the inflammatory response, and IL 1 may serve in the same role for the preparation and provocation of the local Shwartzman reaction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485678

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

2.  Effects of IL-1 muteins on cartilage degradation and as inducers of acute inflammation.

Authors:  M A Pratta; E C Arner; B L Rule; W Galbraith
Journal:  Agents Actions       Date:  1991-09

Review 3.  Will complex carbohydrate ligands of vascular selectins be the next generation of non-steroidal anti-inflammatory drugs?

Authors:  J L Winkelhake
Journal:  Glycoconj J       Date:  1991-10       Impact factor: 2.916

4.  Glomerular cells and macrophages in the progression of experimental focal and segmental glomerulosclerosis.

Authors:  K Matsumoto; R C Atkins
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

Review 5.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

6.  Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes.

Authors:  S N Vogel; E N Kaufman; M D Tate; R Neta
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

7.  Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells.

Authors:  S H P Oliveira; C Canetti; R A Ribeiro; F Q Cunha
Journal:  Inflammation       Date:  2008-02       Impact factor: 4.092

8.  Role of resident macrophages in canatoxin-induced in vivo neutrophil migration.

Authors:  C Barja-Fidalgo; C R Carlini; J A Guimarães; C A Flores; F Q Cunha; S H Ferreira
Journal:  Inflammation       Date:  1992-02       Impact factor: 4.092

9.  Elevated levels of GM-CSF and IL-1 in the serum, peritoneal and pleural cavities of GM-CSF transgenic mice.

Authors:  A J Gearing; D Metcalf; J G Moore; N A Nicola
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

10.  Effect of soluble P55 tumour-necrosis factor binding fusion protein on the local Shwartzman and Arthus reactions.

Authors:  K E Norman; T J Williams; M Feldmann; A G Rossi
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.